Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-MAP Triple Antibiotic Therapy in Crohn's Disease
NCT00513552Phase 4Withdrawn
- Sponsor
- MedStar Health Research Institute
- Start
- Jul 2007
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rifabutin, clarithromycin, clofazimine in Crohn's disease, sponsored by MedStar Health Research Institute. Planned start Jul 2007; status: withdrawn.
02
Drugs
rifabutinclarithromycinclofazimine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00513552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513552.